Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA
The high-throughput test combines CRISPR technology with an automated liquid handling platform from Agilent.
Stanford researchers said the cost of their approach is in line with Illumina sequencing but did not share data on error rate and other benchmarks at this time.
Metagenomi Raises $175M in Series B Financing Round
The company said it will use the new funding to further develop its gene editing tools and advance its therapeutic programs toward the clinic.
Fluidigm Obtains $250M Investment, Changing Name to Standard BioTools
The firm intends to simplify the design and execution of deep cell profiling, and standardize sample analysis with reproducible workflows and automation.
SomaLogic's Illumina Codevelopment Deal Suggests Future of Label-Based Proteomics Lies in NGS
Premium
The assay development deal was "necessary to remain competitive" for SomaLogic, according to MD Anderson proteomics researcher Philip Lorenzi.